Skip to main content

Table 2 Case definition criteria and results

From: Validation of adult asthma case definitions for primary care sentinel surveillance

Case Definition

Inclusion Criteria (Any One Of)

Exclusion criteria

SN

SP

PPV

NPV

YI

ICD-9 billing

Encounter diagnosis

Health condition

Medications

1*

1 of: 493

    

0.35

0.99

0.78

0.93

0.34

2

 

1 of: “asthma”

OR

1 of: 493 (asthma)

   

0.75

0.97

0.74

0.97

0.72

3*

  

1 of: “asthma”

OR

1 of: 493 (asthma)

  

0.04

1.00

0.60

0.91

0.04

4

1 of: 493

1 of: “asthma”

OR

1 of: 493 (asthma)

   

0.81

0.96

0.70

0.98

0.77

5

1 of: 493

1 of: “asthma”

OR

1 of: 493 (asthma)

  

Billing

Any of:

491 (chronic bronchitis),

492 (emphysema),

496 (COPD)

0.81

0.96

0.71

0.98

0.77

6

1 of: 493

1 of: “asthma”

OR

1 of: 493 (asthma)

  

Encounter Diagnosis

Any of:

“asthma*query”

“query*asthma”

“asthma*?”

“?*asthma”

0.81

0.96

0.70

0.98

0.77

7

1 of: 493

1 of: “asthma”

OR

1 of: 493 (asthma)

  

Billing

Any of:

491 (chronic bronchitis),

492 (emphysema),

496 (COPD)

AND/OR

Encounter Diagnosis

Any of:

“asthma*query”

“query*asthma”

“asthma*?”

“?*asthma”

0.81

0.96

0.71

0.98

0.77

8

1 of: 493

1 of: “asthma”

OR

1 of: 493 (asthma)

1 of: “asthma”

OR

1 of: 493 (asthma)

  

0.81

0.96

0.70

0.98

0.77

9

1 of: 493

1 of: “asthma”

OR

1 of: 493 (asthma)

1 of: “asthma”

OR

1 of: 493 (asthma)

 

Billing

Any of:

491 (chronic bronchitis),

492 (emphysema),

496 (COPD)

0.81

0.96

0.71

0.98

0.77

10

1 of: 493

1 of: “asthma”

OR

1 of: 493 (asthma)

1 of: “asthma”

OR

1 of: 493 (asthma)

 

Encounter Diagnosis

Any of:

“asthma*query”

“query*asthma”

“asthma*?”

“?*asthma”

0.81

0.96

0.70

0.98

0.77

11

1 of: 493

1 of: “asthma”

OR

1 of: 493 (asthma)

1 of: “asthma”

OR

1 of: 493 (asthma)

 

Billing

Any of:

491 (chronic bronchitis),

492 (emphysema),

496 (COPD)

AND/OR

Encounter Diagnosis

Any of:

“asthma*query”

“query*asthma”

“asthma*?”

“?*asthma”

0.81

0.96

0.71

0.98

0.77

12

2 of: 493

2 of: “asthma”

OR

2 of: 493 (asthma)

1 of: “asthma”

OR

1 of: 493 (asthma)

  

0.78

0.97

0.75

0.98

0.75

13†

2 of: 493

2 of: “asthma”

OR

2 of: 493 (asthma)

1 of: “asthma”

OR

1 of: 493 (asthma)

 

Encounter Diagnosis/Health Condition

“asthma*query”

“query*asthma”

“asthma*?”

“?*asthma”

0.78

0.97

0.75

0.98

0.75

14

1 of: 493

1 of: “asthma”

OR

1 of: 493 (asthma)

1 of: “asthma”

OR

1 of: 493 (asthma)

Any medication from asthma medication list

Medications

LAMA (monotherapy)

LABA

(monotherapy)

LAMA/LABA (monotherapy)

0.85

0.93

0.57

0.98

0.78

Medication

Case Definition

Inclusion Criteria (Any One Of)

Exclusion Criteria

SN

SP

PPV

NPV

YI

#1

#2

M-1

SABA

Budesonide/formoterol

Any other respiratory medication on medication list

0.35

0.96

0.47

0.93

0.31

M-2

SABA + ICS

SABA + LTRA

Any other respiratory medication on medication list

0.10

0.98

0.39

0.91

0.08

M-3

ICS

 

Any other respiratory medication on medication list

0.08

0.98

0.32

0.91

0.06

M-4

SABA + ICS/LABA

 

Any other respiratory medication on medication list

0.18

0.99

0.93

0.92

0.17

M-5

SABA + (ICS/LABA/LAMA OR ICS/LABA + LAMA OR ICS/LABA + LTRA OR ICS/LABA/LAMA + LTRA)

ICS/LABA/LAMA OR ICS/LABA + LAMA OR ICS/LABA + LTRA OR ICS/LABA/LAMA + LTRA

Any other respiratory medication on medication list

0.08

0.99

0.67

0.91

0.07

M-6

Biologics

 

Any other respiratory medication on medication list

0

0

0

0

-

M-7

Any medication from asthma medications list

 

LAMA (monotherapy)

LABA (monotherapy)

LAMA/LABA (monotherapy)

0.76

0.9

0.45

0.97

0.66

  1. *Adapted from Xi et al. (2015)
  2. †Adapted from Cave et al. (2020)
  3. LABA Long-acting β-agonist, LAMA Long-acting muscarinic antagonist
  4. TP True Positive, FP False Positive, FN False Negative, TN True Negative, SN Sensitivity, SP Specificity, PPV Positive Predictive Value, NPV Negative Predictive Value, YI Youden’s Index
  5. ICS Inhaled corticosteroid, LABA Long-acting β-agonist, LAMA Long-acting muscarinic antagonist, LTRA Leukotriene receptor antagonist, SABA Short-acting β-agonist, SAMA Short-acting muscarinic antagonist
  6. TP True Positive, FP False Positive, FN False Negative, TN True Negative, SN Sensitivity, SP Specificity, PPV Positive Predictive Value, NPV Negative Predictive Value, YI Youden’s Index